The in vivo study of inflammasome NOD-like receptor protein 3 (NLRP3) as a starting point for the development of new innovative migraine drugs
FENS Forum 2024 · University of Ferrara
Jun 25, 2024
We use cookies for analytics.
Jun 25, 2024
Jun 25, 2024
Jun 25, 2024